Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.
Home » Merck in Pact for Chinese Obesity Drug in Nearly $2 Billion Deal
Merck in Pact for Chinese Obesity Drug in Nearly $2 Billion Deal
Login
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Related Posts
Trending Topics
Search
No Result
View All Result